Eikonoklastes Therapeutics
Pre-clinicalEikonoklastes Therapeutics is rapidly developing disruptive treatments for today’s most challenging diseases.
Founded
2019
Focus
Biologics
About
Eikonoklastes Therapeutics is rapidly developing disruptive treatments for today’s most challenging diseases.
Funding History
2Total raised: $16.7M
Series A$12.5MUndisclosedNov 15, 2022
Seed$4.2MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile